Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,360.00
+250.00 (4.89%)
Jul 1, 2026, 9:20 AM KST
Market Cap118.85B -47.5%
Revenue (ttm)n/a +13,737.3%
Net Incomen/a
EPSn/a
Shares Out 23.26M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume144,130
Open5,110.00
Previous Close5,110.00
Day's Range4,900.00 - 5,380.00
52-Week Range3,850.00 - 11,520.00
Beta0.66
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Vaxcell-Bio Therapeutics

Vaxcell-Bio Therapeutics Co., Ltd. develops and anticancer immunotherapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 323990
Full Company Profile

Financial Performance

In 2024, Vaxcell-Bio Therapeutics's revenue was 1.90 billion, an increase of 13737.28% compared to the previous year's 13.72 million. Losses were -10.62 billion, 3.40% more than in 2023.

Financial Statements